eMedicine Specialties > Dermatology > Metabolic Diseases

Avitaminosis A

Author: Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Coauthor(s): Santiago A Centurion, MD, Staff Physician, Department of Dermatology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey; Cristina S Solis, RN, BSN, Consulting Staff, Department of Dermatology, UMDNJ-New Jersey Medical School; Pere Gascon, MD, PhD, Professor and Director, Division of Medical Oncology, Institute of Hematology and Medical Oncology, IDIBAPS, University of Barcelona Faculty of Medicine, Spain
Contributor Information and Disclosures

Updated: Apr 29, 2008

Introduction

Background

Vitamin A can be considered the most important vitamin in supporting animal life. Deficiency occurs in endemic proportions in developing countries and is considered to be the most common cause of blindness in children throughout the world. Besides its essential role in vision, vitamin A is also important in cellular differentiation (eg, growth, reproduction, immune response) and in maintenance of epithelial integrity. No nutritional deficiency is more synergistic with infection than vitamin A. The 2 main mechanisms involved in the prevention of disease are the effect of vitamin A on the immune system and on epithelial integrity.

In areas where vitamin A deficiency (VAD) is prevalent, vitamin A repletion reduces child mortality rates by an average of 23%.1 Biannual vitamin A supplementation is a cost-effective and high-impact child survival intervention in countries such as Mozambique.

Although VAD manifestations are more common in underdeveloped countries, they are evident in the United States when induced by liver cirrhosis, malnutrition, or alcoholism.2

The eMedicine articles Vitamin A Deficiency and Vitamin A Toxicity may be helpful resources. Additionally, the Medscape CME course Vitamin D Deficiency: A Risk Factor for Heart Disease and the Medscape Nutrition Resource Center might of interest.

Pathophysiology

When ingested in the presence of fat, vitamin A is well absorbed from the intestinal lumen. It is metabolized, in part, in the intestinal mucosa and is then carried via chylomicra to the liver and other tissues. Most of the vitamin A in the liver is stored as retinyl esters in specialized cells termed stellate cells. Retinol is transported in the plasma on a specific protein called retinol-binding protein.

Once within tissues, retinol is bound by cellular retinoid-binding proteins, cellular retinoid-binding protein I (CRBPI) and cellular retinoid-binding protein II (CRBPII). In these complexes, retinol may be either esterified or further oxidized via retinol to retinoic acid, which ultimately binds to a set of transcription factors in the nucleus. Intracellular retinol in peripheral tissues can also combine with plasma retinol-binding protein within that tissue, or it can be incorporated into retinyl esters in lipoproteins. The cycling between the major storage organs, such as the liver, and epithelial tissues that require vitamin A for cellular differentiation is extensive and efficient.

Dietary vitamin A not absorbed in the intestine is excreted in the feces, and inactivated metabolic derivatives are primarily excreted in the urine. When vitamin A intake is low, the absorption efficiency remains high, carotenoid cleavage is enhanced, the plasma transport remains at essentially normal levels, recycling and utilization mechanisms become more efficient, and the excretion of metabolites markedly decreases. When vitamin A intakes are high, the absorption efficiency is reduced, the plasma transport of vitamin A remains the same, recycling becomes less efficient, the oxidation of vitamin A is enhanced, biliary excretion markedly increases, and urinary and fecal excretion is augmented.
 
Thus, under normal physiological conditions, the function of vitamin A is minimally affected by wide variations of intake. Marked reductions in absorption efficiency, whether due to disease, parasitic infestation, or lack of fat in the diet, and impaired liver and kidney functions adversely affect vitamin A status.

Deficiencies of vitamin A depress both humoral immunity and cell-mediated immunity. The principal effects of vitamin A inadequacy on immune function may be a consequence of impaired growth and differentiation of myeloid tissues. Vitamin A has been labeled the anti-infection vitamin from early in this century, and the reason for this may be due to the depression in plasma retinol caused by infection. The depression in serum retinol levels may expose an individual to inadequate plasma vitamin A concentrations in areas where the dietary intake was already marginal. In particular, vitamin A is specifically important for the integrity of the epithelium and the maintenance of mucosal secretions, which, if impaired, may increase exposure to microorganisms and the risk of infection.

Epithelial tissues of the eyes, the lungs, and the gut are impaired by VAD. These are all tissues where epithelial cell turnover is high. In humans, numerous studies using the impression cytology test have shown that low circulating vitamin A levels are associated with an increased risk of epithelial damage in the eye. Impaired gut integrity is common in malnutrition. Damage to the integrity of epithelia and mucosal barriers facilitates translocation of microorganisms and contributes to the increased severity of infections. Thus, low plasma vitamin A levels may compromise immune function by impairing epithelial integrity and by depressing lymphocyte numbers, and, although the capacity of immune cells may still be normal, the overall immune response is depressed.

Vitamin A has essentially 2 roles in ocular metabolism. First, in the retina, vitamin A serves as a precursor to the photosensitive visual pigments that participate in the initiation of neural impulses from the photoreceptors. Second, it is necessary for conjunctival epithelial cell ribonucleic acid (RNA) and glycoprotein synthesis, which helps to maintain the conjunctival mucosa and the corneal stroma.

The retina contains 2 distinct photoreceptor systems, the rods and the cones. The rods are responsible for vision in dim or low light, and the cones are responsible for color vision and vision in bright light. Vitamin A is the backbone of the visual pigments for both the rods and the cones, the major difference being the type of protein that is bound to the retinol. In rod cells, the aldehyde form of vitamin A (retinol) and the protein opsin combine to create rhodopsin, which is the photosensitive pigment. When light hits the rod cells, the pigment isomerizes, which leads to the nerve impulse and results in the visual signal.

The precise mechanism is still not known, but vitamin A is necessary for the maintenance of the specialized epithelial surfaces of the body. A lack of vitamin A leads to atrophic changes in the normal mucosal surface, with loss of goblet cells, and replacement of the normal epithelium by an inappropriate keratinized stratified squamous epithelium. In addition, the substantia propria of the cornea breaks down and liquefies, resulting in keratomalacia.

Loewenthal first described the cutaneous findings associated with VAD in 1933 when he described polygonal papules on the extensor surfaces of the extremities of patients who also had night blindness and xerophthalmia. The skin changes were later coined phrynoderma by Nicholls when he described the findings in East African workers with VAD.

Frequency

United States

In developed countries, VAD is a rare condition.

International

An estimated one fourth to one half million children annually develop keratomalacia and become partially or totally blind, and 13-14 million children exhibit xerophthalmia of lesser severity. The World Health Organization (WHO) estimates that approximately 190 million preschool-aged children live in areas where VAD is known to occur. These areas are mainly in the developing world where an estimated 40% (70-80 million) of the children are likely to be subclinically deficient. Thus, 90-100 million children worldwide are likely to be vitamin A deficient, with the consequence that their health and likelihood of survival are compromised. In 1 Kakuma refugee camp in Kenya and 7 refugee camps in Nepal, VAD was found in 15% of adolescents in Kenya and 30% of adolescents in Nepal.3

Mortality/Morbidity

Mortality rates of 30-60% or more occur for children with keratomalacia and mild xerophthalmia, and the fatality risk for those even subclinically deficient is increased by 20-30%. At any one time, as many as 230 million children are at risk of clinical/subclinical VAD, and, annually, more than 1 million deaths in children are associated with VAD.

Sex

Females and males are affected equally.

Age

Avitaminosis A is most common in children aged 1-6 years, with the most severe, blinding complications affecting children aged 6 months to 3 years. The incidence is skewed toward children because infants born to mothers who are vitamin A deficient have small vitamin A stores at birth and, subsequently, get little from breastfeeding. Furthermore, the demands of rapid growth and susceptibility to infectious disease place an even greater demand on the meager body stores of vitamin A they do possess.

Clinical

History

Avitaminosis A generally accompanies states of severe malnutrition, such as kwashiorkor and marasmus, and it may be suspected in individuals with an unusual susceptibility to infectious diseases, such as measles.

  • Impaired vision, particularly at night: Because of the essential role of vitamin A in photoreceptor function, night blindness is the earliest and most common symptom of its deficiency.
  • Xerophthalmia: VAD may produce xerophthalmia. Its ocular manifestations include conjunctival and corneal xerosis (drying), keratomalacia (corneal necrosis/ulceration), nyctalopia (night blindness), and Bitot spots (conjunctival lesions).2 Maternal night blindness is common during pregnancy in poor countries. Maternal night blindness during pregnancy has been associated with low birthweight, morbidity, and poor growth in South India.4
  • Photophobia
  • Erythema
  • Dry, thickened skin (toad skin)
  • Diarrhea

Physical

The most distinctive clinical features of VAD are present in the ocular system; however, numerous skin findings have also been reported. Clinical findings include the following:

  • Conjunctival xerosis is typically found on the temporal, interpalpebral, and bulbar conjunctivae. Characteristically, it is seen as a dry, granular patch that can exhibit thickening, wrinkling, loss of pigmentation, and transparency.
  • Bitot spots are triangular, perilimbal, gray plaques of keratinized conjunctival debris overlying an area of conjunctival xerosis.
  • Xerophthalmia is an instability of the precorneal tear film, which can lead to a dull corneal appearance and a superficial punctate keratopathy noted with the use of fluorescein.
  • Corneal ulcerations can be partial or full thickness. Keratomalacia is a full-thickness liquefactive necrosis of the cornea. Clinically, it is a sharply demarcated lesion with an opaque, grayish yellow appearance. The stroma can slough, either leaving a descemetocele or, in severe cases, causing perforation and loss of the anterior chamber.
  • Generalized xerosis with fine wrinkles and scales may be present.
  • Phrynoderma (follicular hyperkeratosis) is characterized by red-brown follicular papules that are approximately 2-6 mm in diameter, with a central keratotic spinous plug. These lesions are usually found clustered around the bony prominences of the elbows and the knees, although they may extend up the thighs and the arms.

Causes

VAD occurs where diets contain insufficient amounts of vitamin A for growth and development, physiological functions, and periods of added stress due to illness.

  • Avitaminosis A is often diagnosed in persons with alcoholism who are malnourished and in patients who are chronically ill with intestinal malabsorption disorders, such as sprue, bypass surgery, cystic fibrosis, pancreatitis, metastatic cancer, regional enteritis, and chronic gastroenteritis. Other patients with avitaminosis A include those with liver disease that causes abnormal or decreased storage of vitamin A. Patients receiving total parenteral nutrition can also show signs and symptoms of avitaminosis A secondary to loss of vitamin A with prolonged use.
  • Avitaminosis A is a problem wherever the combination of vitamin A and protein deficiency exists. In developed countries, VAD is a rare condition. However, it is a problem of enormous magnitude worldwide, particularly in the underdeveloped regions of Asia, where the diet often consists of little more than rice. Avitaminosis A is fairly well controlled in much of Latin America and the Caribbean, with the exception of Haiti, where the incidence is as high as that in some Asian countries. Some reports suggest that the prevalence of xerophthalmia in parts of Africa may be as high as that found in Southeast Asia, whereas in other areas, particularly West Africa, the prevalence is lower, mostly because the red palm oil widely used for cooking is a good source of vitamin A supplementation. In endemic countries, the disease is largely confined to lower socioeconomic groups who cannot afford vitamin A–rich foods.
  • Women of childbearing age are at high risk of VAD and its consequences because of increased vitamin A requirements during pregnancy and lactation. Their newborns, having been vitamin A depleted, require vitamin A supplements. Otherwise, after the initial 4-6 months of breastfeeding, the babies are likely to develop VAD.
  • Infections, such as measles, may precipitate a child into clinical VAD.5,6
  • VAD can be assumed to have profound effects because vitamin A supplementation reduces child mortality and severe morbidity in underdeveloped countries. Vitamin A supplementation enhances infants' immune responses to hepatitis B vaccine.7

More on Avitaminosis A

Overview: Avitaminosis A
Differential Diagnoses & Workup: Avitaminosis A
Treatment & Medication: Avitaminosis A
Follow-up: Avitaminosis A
References

References

  1. Aguayo VM, Kahn S, Ismael C, Meershoek S. Vitamin A deficiency and child mortality in Mozambique. Public Health Nutr. Feb 2005;8(1):29-31. [Medline].

  2. Roncone DP. Xerophthalmia secondary to alcohol-induced malnutrition. Optometry. Mar 2006;77(3):124-33. [Medline].

  3. Woodruff BA, Blanck HM, Slutsker L, Cookson ST, Larson MK, Duffield A, et al. Anaemia, iron status and vitamin A deficiency among adolescent refugees in Kenya and Nepal. Public Health Nutr. Feb 2006;9(1):26-34. [Medline].

  4. Tielsch JM, Rahmathullah L, Katz J, Thulasiraj RD, Coles C, Sheeladevi S, et al. Maternal night blindness during pregnancy is associated with low birthweight, morbidity, and poor growth in South India. J Nutr. Apr 2008;138(4):787-92. [Medline].

  5. Barclay AJ, Foster A, Sommer A. Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J (Clin Res Ed). Jan 31 1987;294(6567):294-6. [Medline].

  6. West CE. Vitamin A and measles. Nutr Rev. Feb 2000;58(2 Pt 2):S46-54. [Medline].

  7. Newton S, Owusu-Agyei S, Ampofo W, Zandoh C, Adjuik M, Adjei G, et al. Vitamin A Supplementation Enhances Infants' Immune Responses to Hepatitis B Vaccine but Does Not Affect Responses to Haemophilus influenzae Type b Vaccine. J Nutr. May 2007;137(5):1272-7. [Medline].

  8. Low JW, Arimond M, Osman N, Cunguara B, Zano F, Tschirley D. A Food-Based Approach Introducing Orange-Fleshed Sweet Potatoes Increased Vitamin A Intake and Serum Retinol Concentrations in Young Children in Rural Mozambique. J Nutr. May 2007;137(5):1320-1327. [Medline].

  9. Aguayo VM, Baker SK. Vitamin A deficiency and child survival in sub-Saharan Africa: a reappraisal of challenges and opportunities. Food Nutr Bull. Dec 2005;26(4):348-55. [Medline].

  10. Zeba AN, Sorgho H, Rouamba N, Zongo I, Rouamba J, Guiguemdé RT, et al. Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial. Nutr J. Jan 31 2008;7:7. [Medline].

  11. Ag Bendech M, Malvy DJ, Chauliac M. [Vitamin A deficiency: epidemiological aspects and control methods]. Sante. Sep-Oct 1997;7(5):309-16. [Medline].

  12. Ahmed F. Vitamin A deficiency in Bangladesh: a review and recommendations for improvement. Public Health Nutr. Mar 1999;2(1):1-14. [Medline].

  13. Amedee-Manesme O, Mourey MS, Hanck A, Therasse J. Vitamin A relative dose response test: validation by intravenous injection in children with liver disease. Am J Clin Nutr. Aug 1987;46(2):286-9. [Medline].

  14. Anderson VP, Jack S, Monchy D, Hem N, Hok P, Bailey KB, et al. Co-existing micronutrient deficiencies among stunted Cambodian infants and toddlers. Asia Pac J Clin Nutr. 2008;17(1):72-9. [Medline].

  15. Asagba SO, Isamah GK, Ossai EK, Ekakitie AO. Effect of oral exposure to cadmium on the levels of vitamin A and lipid peroxidation in the eye. Bull Environ Contam Toxicol. Jan 2002;68(1):18-21. [Medline].

  16. Azaïs-Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J Clin Nutr. May 2000;71(5 Suppl):1325S-33S. [Medline].

  17. Beisel WR. Single nutrients and immunity. Am J Clin Nutr. Feb 1982;35(2 Suppl):417-68. [Medline].

  18. Bendech MA, Cusack G, Konate F, Toure A, Ba M, Baker SK. National Vitamin A Supplementation Coverage Survey among 6-59 Months Old Children in Guinea (West Africa). J Trop Pediatr. Apr 25 2007;[Medline].

  19. Caminha MD, Diniz AD, Falbo AR, Arruda IK, Serva VB, Albuquerque LL, et al. Serum Retinol Concentrations in Hospitalized Severe Protein-energy Malnourished Children. J Trop Pediatr. Apr 1 2008;[Medline].

  20. Chandra RK. Increased bacterial binding to respiratory epithelial cells in vitamin A deficiency. BMJ. Oct 1 1988;297(6652):834-5. [Medline].

  21. Chandra RK. Nutrition and immunity. Trop Geogr Med. Jul 1988;40(3):S46-51. [Medline].

  22. Cheung WM. Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Applications, edited by M.A. Livrea, Wiley-VCH, 2000, 300 p. Biochimie. Oct 2001;83(10):987-8.

  23. Christian P, West KP Jr. Interactions between zinc and vitamin A: an update. Am J Clin Nutr. Aug 1998;68(2 Suppl):435S-441S. [Medline].

  24. Chugh R, Puri S. Affluent adolescent girls of Delhi: eating and weight concerns. Br J Nutr. Oct 2001;86(4):535-42. [Medline].

  25. Craft NE. Innovative approaches to vitamin A assessment. J Nutr. May 2001;131(5):1626S-30S. [Medline].

  26. Cusick SE, Tielsch JM, Ramsan M, Jape JK, Sazawal S, Black RE, et al. Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children. Am J Clin Nutr. Aug 2005;82(2):406-12. [Medline].

  27. de Pee S, West CE. Dietary carotenoids and their role in combating vitamin A deficiency: a review of the literature. Eur J Clin Nutr. Jul 1996;50 Suppl 3:S38-53. [Medline].

  28. Duggan C, Fawzi W. Micronutrients and child health: studies in international nutrition and HIV infection. Nutr Rev. Nov 2001;59(11):358-69. [Medline].

  29. Duggan MB, Milner RD. The maintenance energy requirement for children: an estimate based on a study of children with infection associated underfeeding. Am J Clin Nutr. Jun 1986;43(6):870-8. [Medline].

  30. Elefant E. [Vitamin A. Consequence of a deficiency, of excessive vitamin A, and value of systematic supplementation]. J Gynecol Obstet Biol Reprod (Paris). 1997;26(3 Suppl):95-9. [Medline].

  31. Figueiredo JF, Lorenzato MM, Silveira SA, Passos AD, Rodrigues Md, Galvao LC, et al. [Survival and infectious processes in pacients with AIDS: analysis based on initial serum vitamin A levels]. Rev Soc Bras Med Trop. Sep-Oct 2001;34(5):429-35. [Medline].

  32. Flores H, Campos F, Araujo RC, Underwood BA. Assessment of marginal vitamin A deficiency in Brazilian children using the relative dose response procedure. Am J Clin Nutr. Dec 1984;40(6):1281-9. [Medline].

  33. Gadomski AM, Kjolhede CL, Wittpenn J, Bulux J, Rosas AR, Forman MR. Conjunctival impression cytology (CIC) to detect subclinical vitamin A deficiency: comparison of CIC with biochemical assessments. Am J Clin Nutr. Mar 1989;49(3):495-500. [Medline].

  34. Gerster H. Vitamin A--functions, dietary requirements and safety in humans. Int J Vitam Nutr Res. 1997;67(2):71-90. [Medline].

  35. Gupta M, Jora R, Bhatia R, Pareek A. Keratomalacia in a neonate secondary to maternal vitamin A deficiency. Indian J Pediatr. Oct 2005;72(10):881-2. [Medline].

  36. Handelman GJ. The evolving role of carotenoids in human biochemistry. Nutrition. Oct 2001;17(10):818-22. [Medline].

  37. Harris EW, Loewenstein JI, Azar D. Vitamin A deficiency and its effects on the eye. Int Ophthalmol Clin. 1998;38(1):155-61. [Medline].

  38. Hu W, Tong S, Oldenburg B, Feng X. Serum vitamin A concentrations and growth in children and adolescents in Gansu Province, China. Asia Pac J Clin Nutr. 2001;10(1):63-6. [Medline].

  39. Kennedy CM, Kuhn L, Stein Z. Vitamin A and HIV infection: disease progression, mortality, and transmission. Nutr Rev. Oct 2000;58(10):291-303. [Medline].

  40. Kilic SS, Kezer EY, Ilcol YO, Yakut T, Aydin S, Ulus IH. Vitamin a deficiency in patients with common variable immunodeficiency. J Clin Immunol. May 2005;25(3):275-80. [Medline].

  41. Kjolhede CL, Gadomski AM, Wittpenn J, Bulux J, Rosas AR, Solomons NW, et al. Conjunctival impression cytology: feasibility of a field trial to detect subclinical vitamin A deficiency. Am J Clin Nutr. Mar 1989;49(3):490-4. [Medline].

  42. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. Jun 1999;69(6):1071-85. [Medline].

  43. Looker AC, Johnson CL, Woteki CE, Yetley EA, Underwood BA. Ethnic and racial differences in serum vitamin A levels of children aged 4-11 years. Am J Clin Nutr. Feb 1988;47(2):247-52. [Medline].

  44. Lower GM Jr, Kanarek MS. Retinoids, urinary bladder carcinogenesis, and chemoprevention: a review and synthesis. Nutr Cancer. 1981;3(2):109-15. [Medline].

  45. Maden M. The role of retinoic acid in embryonic and post-embryonic development. Proc Nutr Soc. Feb 2000;59(1):65-73. [Medline].

  46. McCullough FS, Northrop-Clewes CA, Thurnham DI. The effect of vitamin A on epithelial integrity. Proc Nutr Soc. May 1999;58(2):289-93. [Medline].

  47. McDowell EM, Keenan KP, Huang M. Effects of vitamin A-deprivation on hamster tracheal epithelium. A quantitative morphologic study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(2):197-219. [Medline].

  48. McDowell EM, Keenan KP, Huang M. Restoration of mucociliary tracheal epithelium following deprivation of vitamin A. A quantitative morphologic study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(2):221-40. [Medline].

  49. McLaren DS. Vitamin A deficiency disorders. J Indian Med Assoc. Aug 1999;97(8):320-3. [Medline].

  50. Mejia LA, Arroyave G. The effect of vitamin A fortification of sugar on iron metabolism in preschool children in Guatemala. Am J Clin Nutr. Jul 1982;36(1):87-93. [Medline].

  51. Mertens TE, Cousens SN, Feachem RG. Evidence of a prolonged association between low birthweight and paediatric diarrhoea in Sri Lanka. Trans R Soc Trop Med Hyg. 1987;81(2):196. [Medline].

  52. Milton RC, Reddy V, Naidu AN. Mild vitamin A deficiency and childhood morbidity--an Indian experience. Am J Clin Nutr. Nov 1987;46(5):827-9. [Medline].

  53. Mora JO, Gueri M, Mora OL. Vitamin A deficiency in Latin America and the Caribbean: an overview. Rev Panam Salud Publica. Sep 1998;4(3):178-86. [Medline].

  54. Morriss-Kay GM, Ward SJ. Retinoids and mammalian development. Int Rev Cytol. 1999;188:73-131. [Medline].

  55. Muslimatun S, Schmidt MK, Schultink W, West CE, Hautvast JA, Gross R, et al. Weekly supplementation with iron and vitamin A during pregnancy increases hemoglobin concentration but decreases serum ferritin concentration in Indonesian pregnant women. J Nutr. Jan 2001;131(1):85-90. [Medline].

  56. Muslimatun S, Schmidt MK, West CE, Schultink W, Hautvast JG, Karyadi D. Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women. J Nutr. Oct 2001;131(10):2664-9. [Medline].

  57. Nabakwe EC, Lichtenbelt WV, Ngare DK, Wierik M, Westerterp KR, Owino OC. Vitamin a deficiency and anaemia in young children living in a malaria endemic district of western Kenya. East Afr Med J. Jun 2005;82(6):300-6. [Medline].

  58. Natadisastra G, Wittpenn JR, West KP Jr, Muhilal, Sommer A. Impression cytology for detection of vitamin A deficiency. Arch Ophthalmol. Sep 1987;105(9):1224-8. [Medline].

  59. Nestel P, Trumbo P. The role of provitamin A carotenoids in the prevention and control of vitamin A deficiency. Arch Latinoam Nutr. Sep 1999;49(3 Suppl 1):26S-33S. [Medline].

  60. Niles RM. Vitamin A and cancer. Nutrition. Jul-Aug 2000;16(7-8):573-6. [Medline].

  61. Pal R, Sagar V. Antecedent risk factors of xerophthalmia among Indian rural preschool children. Eye Contact Lens. Mar 2008;34(2):106-8. [Medline].

  62. Petkovich PM. Retinoic acid metabolism. J Am Acad Dermatol. Nov 2001;45(5):S136-42. [Medline].

  63. Pilch SM. Analysis of vitamin A data from the health and nutrition examination surveys. J Nutr. Apr 1987;117(4):636-40. [Medline].

  64. Pinnock CB, Douglas RM, Badcock NR. Vitamin A status in children who are prone to respiratory tract infections. Aust Paediatr J. May 1986;22(2):95-9. [Medline].

  65. Raila J, Mathews U, Schweigert FJ. Plasma transport and tissue distribution of beta-carotene, vitamin A and retinol-binding protein in domestic cats. Comp Biochem Physiol A Mol Integr Physiol. Nov 2001;130(4):849-56. [Medline].

  66. Ramakrishna T. Vitamins and brain development. Physiol Res. 1999;48(3):175-87. [Medline].

  67. Rondo PH, Abbott R, Tomkins AM. Vitamin A and neonatal anthropometry. J Trop Pediatr. Oct 2001;47(5):307-10. [Medline].

  68. Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral responses. FASEB J. Jul 1996;10(9):979-85. [Medline].

  69. Ross DA. Vitamin A and public health: challenges for the next decade. Proc Nutr Soc. Feb 1998;57(1):159-65. [Medline].

  70. Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr. Apr 2000;71(4):878-84. [Medline].

  71. Samba C, Tchibindat F, Houze P, Gourmel B, Malvy D. Prevalence of infant Vitamin A deficiency and undernutrition in the Republic of Congo. Acta Trop. Mar 2006;97(3):270-83. [Medline].

  72. Seeliger M, Biesalski HK. [Vitamin A metabolism and retinal degeneration]. Ophthalmologe. Jun 2001;98(6):520-5. [Medline].

  73. Semba RD, Munasir Z, Akib A, Melikian G, Permaesih D, Muherdiyantiningsih, et al. Integration of vitamin A supplementation with the Expanded Programme on Immunization: lack of impact on morbidity or infant growth. Acta Paediatr. Oct 2001;90(10):1107-11. [Medline].

  74. Senior K. Vitamin A and its impact on human medicine. Lancet. Sep 29 2001;358(9287):1072. [Medline].

  75. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr. Aug 1987;111(2):269-77. [Medline].

  76. Simms W, Ross PS. Vitamin A physiology and its application as a biomarker of contaminant-related toxicity in marine mammals: a review. Toxicol Ind Health. Sep 2001;16(7-8):291-302. [Medline].

  77. Smith J, Steinemann TL. Vitamin A deficiency and the eye. Int Ophthalmol Clin. 2000;40(4):83-91. [Medline].

  78. Solomons NW. Plant sources of vitamin A and human nutriture: how much is still too little?. Nutr Rev. Nov 1999;57(11):350-3. [Medline].

  79. Sommer A. Moving from science to public health programs: lessons from vitamin A. Am J Clin Nutr. Aug 1998;68(2 Suppl):513S-516S. [Medline].

  80. Sommer A. Xerophthalmia and vitamin A status. Prog Retin Eye Res. Jan 1998;17(1):9-31. [Medline].

  81. Sommer A, Katz J, Tarwotjo I. Increased risk of respiratory disease and diarrhea in children with preexisting mild vitamin A deficiency. Am J Clin Nutr. Nov 1984;40(5):1090-5. [Medline].

  82. Sommer A, Tarwotjo I, Katz J. Increased risk of xerophthalmia following diarrhea and respiratory disease. Am J Clin Nutr. May 1987;45(5):977-80. [Medline].

  83. Sommer A, West KP Jr. Impact of vitamin A on childhood mortality. Indian J Pediatr. Jul-Aug 1987;54(4):461-3. [Medline].

  84. Sorg O, Tran C, Saurat JH. Cutaneous vitamins A and E in the context of ultraviolet- or chemically-induced oxidative stress. Skin Pharmacol Appl Skin Physiol. Nov-Dec 2001;14(6):363-72. [Medline].

  85. Stephens D, Jackson PL, Gutierrez Y. Subclinical vitamin A deficiency: a potentially unrecognized problem in the United States. Pediatr Nurs. Sep-Oct 1996;22(5):377-89, 456. [Medline].

  86. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001;21:167-92. [Medline].

  87. Stephenson LS, Latham MC, Ottesen EA. Global malnutrition. Parasitology. 2000;121 Suppl:S5-22. [Medline].

  88. Su GM, Sefton RM, Murray M. Down-regulation of rat hepatic microsomal cytochromes P-450 in microvesicular steatosis induced by orotic acid. J Pharmacol Exp Ther. Dec 1999;291(3):953-9. [Medline].

  89. Tamai H. [Vitamin A deficiency and neurological findings]. Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):102-3. [Medline].

  90. Tanumihardjo SA, Olson JA. A modified relative dose-response assay employing 3,4-didehydroretinol (vitamin A2) in rats. J Nutr. May 1988;118(5):598-603. [Medline].

  91. Underwood BA. From research to global reality: the micronutrient story. J Nutr. Feb 1998;128(2):145-51. [Medline].

  92. Underwood BA. Hypovitaminosis A: international programmatic issues. J Nutr. Aug 1994;124(8 Suppl):1467S-1472S. [Medline].

  93. Underwood BA. Methods for assessment of vitamin A status. J Nutr. Nov 1990;120 Suppl 11:1459-63. [Medline].

  94. Underwood BA. Perspectives from micronutrient malnutrition elimination/eradication programmes. Bull World Health Organ. 1998;76 Suppl 2:34-7. [Medline].

  95. Underwood BA. The role of vitamin A in child growth, development and survival. Adv Exp Med Biol. 352:201-8. [Medline].

  96. Underwood BA. The timing of high-dose vitamin A supplementation to children. Am J Public Health. Sep 1995;85(9):1200-1. [Medline].

  97. Underwood BA. Vitamin A deficiency. Bull World Health Organ. 1998;76 Suppl 2:124-5. [Medline].

  98. Underwood BA, Arthur P. The contribution of vitamin A to public health. FASEB J. Jul 1996;10(9):1040-8. [Medline].

  99. van den Berg H. Vitamin A intake and status. Eur J Clin Nutr. Jul 1996;50 Suppl 3:S7-12. [Medline].

  100. Villamor E, Fawzi WW. Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis. Sep 2000;182 Suppl 1:S122-33. [Medline].

  101. West CE. Meeting requirements for vitamin A. Nutr Rev. Nov 2000;58(11):341-5. [Medline].

  102. Wittpenn JR, Tseng SC, Sommer A. Detection of early xerophthalmia by impression cytology. Arch Ophthalmol. Feb 1986;104(2):237-9. [Medline].

  103. Zile MH. Function of vitamin A in vertebrate embryonic development. J Nutr. Mar 2001;131(3):705-8. [Medline].

Further Reading

Keywords

vitamin A deficiency, VAD, hypovitaminosis A, hyporetinemia, retinol, beta carotene, beta-carotene, keratomalacia, night blindness

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Santiago A Centurion, MD, Staff Physician, Department of Dermatology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey
Santiago A Centurion, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, and Sigma Xi
Disclosure: Nothing to disclose.

Cristina S Solis, RN, BSN, Consulting Staff, Department of Dermatology, UMDNJ-New Jersey Medical School
Disclosure: Nothing to disclose.

Pere Gascon, MD, PhD, Professor and Director, Division of Medical Oncology, Institute of Hematology and Medical Oncology, IDIBAPS, University of Barcelona Faculty of Medicine, Spain
Pere Gascon, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, New York Academy of Medicine, New York Academy of Sciences, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Shyam Verma, MBBS, DVD, FAAD, Adjunct Clinical Assistant Professor, Department of Dermatology, University of Virginia, State University of New York at Stonybrook, Penn State University
Shyam Verma, MBBS, DVD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other

Managing Editor

Jeffrey J Miller, MD, Associate Professor, Department of Dermatology, Penn State University, Milton S Hershey Medical Center
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.